SHSE:688443 (China)
Â
Ordinary Shares - Class A
Â¥
24.83
+1.1 (+4.64%)
Jul 20
Business Description
Chongqing Genrix Biopharmaceutical Co Ltd
ISIN : CNE100006KG8
Share Class Description:
SHSE:688443: Ordinary Shares - Class ATotal Employee Number:
984Compare
Compare
Traded in other countries / regions
688443.China Index Membership
SSE Composite Index IPO Date
2023-06-20Description
Chongqing Genrix Biopharmaceutical Co Ltd is a biopharmaceutical company engaged in the research & development, production and sales of antibody drugs. The company's pipeline includes product candidate that targets Autoimmune Diseases, Infectious Diseases, and Oncology.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.8 | |||||
Equity-to-Asset | 0.48 | |||||
Debt-to-Equity | 0.83 | |||||
Debt-to-EBITDA | -2.25 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.2 | |||||
Beneish M-Score | 0.59 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 580 | |||||
3-Year EBITDA Growth Rate | 13.1 | |||||
3-Year EPS without NRI Growth Rate | 9.3 | |||||
3-Year FCF Growth Rate | 0.7 | |||||
3-Year Book Growth Rate | 244.2 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 85.56 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 37.61 | |||||
9-Day RSI | 45.28 | |||||
14-Day RSI | 46.64 | |||||
3-1 Month Momentum % | -33.15 | |||||
6-1 Month Momentum % | -32.1 | |||||
12-1 Month Momentum % | -32.72 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.78 | |||||
Quick Ratio | 4.57 | |||||
Cash Ratio | 4.27 | |||||
Days Inventory | 1324.03 | |||||
Days Sales Outstanding | 31.99 | |||||
Days Payable | 1558.21 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -10.1 | |||||
Shareholder Yield % | -3.15 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 92.26 | |||||
Operating Margin % | -205 | |||||
Net Margin % | -203.13 | |||||
EBITDA Margin % | -191.53 | |||||
FCF Margin % | -180.34 | |||||
OCF Margin % | -141.32 | |||||
ROE % | -32.66 | |||||
ROA % | -18.53 | |||||
ROIC % | -74.43 | |||||
3-Year ROIIC % | 1.6 | |||||
ROC (Joel Greenblatt) % | -110.05 | |||||
ROCE % | -20 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 32.62 | |||||
PB Ratio | 6.35 | |||||
Price-to-Tangible-Book | 6.53 | |||||
EV-to-EBIT | -14.91 | |||||
EV-to-EBITDA | -14.91 | |||||
EV-to-Revenue | 28.56 | |||||
EV-to-FCF | -15.83 | |||||
| Price-to-Net-Current-Asset-Value | 10.48 | |||||
| Price-to-Net-Cash | 14.96 | |||||
Earnings Yield (Greenblatt) % | -6.71 | |||||
FCF Yield % | -5.5 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Chongqing Genrix Biopharmaceutical Co Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 277.818 | ||
| EPS (TTM) (Â¥) | -1.54 | ||
| Beta | 1.3719 | ||
| 3-Year Sharpe Ratio | -0.15 | ||
| 3-Year Sortino Ratio | -0.21 | ||
| Volatility % | 35.69 | ||
| 14-Day RSI | 46.64 | ||
| 14-Day ATR (Â¥) | 1.595569 | ||
| 20-Day SMA (Â¥) | 23.8775 | ||
| 12-1 Month Momentum % | -32.72 | ||
| 52-Week Range (Â¥) | 20.07 - 37.88 | ||
| Shares Outstanding (Mil) | 366.68 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Chongqing Genrix Biopharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Chongqing Genrix Biopharmaceutical Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Chongqing Genrix Biopharmaceutical Co Ltd Frequently Asked Questions
What is Chongqing Genrix Biopharmaceutical Co Ltd(SHSE:688443)'s stock price today?
The current price of SHSE:688443 is ¥24.83. The 52 week high of SHSE:688443 is ¥37.88 and 52 week low is ¥20.07.
When is next earnings date of Chongqing Genrix Biopharmaceutical Co Ltd(SHSE:688443)?
The next earnings date of Chongqing Genrix Biopharmaceutical Co Ltd(SHSE:688443) is .
Does Chongqing Genrix Biopharmaceutical Co Ltd(SHSE:688443) pay dividends? If so, how much?
Chongqing Genrix Biopharmaceutical Co Ltd(SHSE:688443) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Chongqing Genrix Biopharmaceutical Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers